PQA Annul Meeting,
May 16

On May 16 at the 2024 PQA Annul Meeting, Stephen Jones, VP Advanced Analytics, will join Sheila Botts, Regional Administrator, Clinical Pharmacy Services at Kaiser Permanente, Colorado and Vanessa Campbell, Director, Clinical Pharmacy at UPMC Health Plan to talk about unfavorable social-risk factors (SRF) and how they negatively impact medication adherence and health outcomes.

Working with our payer partners, RxAnte developed a supervised machine learning model to identify at-risk SRF cohorts. Tailored outreach was developed by our clients to identify and address barriers to medication adherence and other health behaviors.

Attendees will learn the impact of SRF on medication adherence and how to develop actionable outreach programs that can deliver better care to at-risk patients.

To learn more about RxAnte’s SRF Queue, go here.

Related Resources

6.29.22

by Patricia Powers, PharmD

How Mosaic’s Comprehensive Pharmacy Support Enables Better Care at Home

As the Director of Clinical Services at Mosaic Pharmacy Service, Patricia Powers, Pharm.D. is responsible for overseeing the development and delivery of clinical services for all Mosaic members, RxAnte’s high-touch pharmacy service. This month we asked Dr. Powers to share her insights around at-home care coordination benefiting both the patient and the health system and how Mosaic’s comprehensive pharmacy support can help enable better care at home.

5.25.22

by Tori Erxleben Rush, PharmD

CMS Announcement for Medicare Advantage Part C and D plans

In early April, the Center for Medicaid and Medicare Services shared its Announcement for Medicare Advantage Part C and D plans, incorporating feedback solicited after an Advance Notice was issued in February 2022. Overall, not much has changed since the Advance Notice, however CMS addressed the comments issued by Medicare Advantage stakeholders like MA organizations and prescription drug plan sponsors.

4.4.22

The need for value-based pharmacy services

There is a strong push among physicians to transition to care models that incentivize fewer, more effective treatments. This same perspective should also be held in pharmacy. As we look to a post-pandemic healthcare system, improvements need to be made to remedy these concerns with focuses on barriers to optimal quality and cost--particularly for the medically complex and socially vulnerable.

PQA Annul Meeting, May 16

Related Resources

How Mosaic’s Comprehensive Pharmacy Support Enables Better Care at Home

CMS Announcement for Medicare Advantage Part C and D plans

The need for value-based pharmacy services

PQA Annul Meeting,
May 16